Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
Explore more from The Transmitter
Organoids missing the TSC2 gene form rogue astrocytes; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 28 September.
Organoids missing the TSC2 gene form rogue astrocytes; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 28 September.
Cerebellar neurons reorient brain activity to differentiate similar behaviors
The findings provide a new perspective on how granule cells help to generalize learning across tasks.
Cerebellar neurons reorient brain activity to differentiate similar behaviors
The findings provide a new perspective on how granule cells help to generalize learning across tasks.
Revisiting the neural correlates of consciousness
Life happens in real time, but experience may be composed in ragtime—like the music genre, full of offbeat notes and uneven rhythms. The assumption that waking life consists of a “stream” of conscious representations has inadvertently led consciousness science to its current impasse.
Revisiting the neural correlates of consciousness
Life happens in real time, but experience may be composed in ragtime—like the music genre, full of offbeat notes and uneven rhythms. The assumption that waking life consists of a “stream” of conscious representations has inadvertently led consciousness science to its current impasse.